In this way, in vitro approaches targeting the MYD88L265-promoted myddosome assembly, which results in a constitutive NF-κB activation, suggested that disruption of this structure inhibits cell survival and promotes apoptosis in ABC DLBCL with MYD88-mutations [66]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.